Terms: = Breast cancer AND NKX2-1, BCH, 7080, ENSG00000136352, P43699, TITF1, TEBP, BHC, NKX2A, TTF-1, NKX2_1, NK-2 AND Treatment
87 results:
1. Synchronous double primary small cell lung cancer and invasive ductal breast carcinoma: a case report.
Gan J; Liu M; Liu F; Wen J; Fu W; Jia J
BMC Pulm Med; 2024 Feb; 24(1):93. PubMed ID: 38388422
[TBL] [Abstract] [Full Text] [Related]
2. "All in one" nanoprobe Au-ttf-1 for target FL/CT bioimaging, machine learning technology and imaging-guided photothermal therapy against lung adenocarcinoma.
Yang Z; Zhang Y; Tang L; Yang X; Song L; Shen C; Zvyagin AV; Li Y; Yang B; Lin Q
J Nanobiotechnology; 2024 Jan; 22(1):22. PubMed ID: 38184620
[TBL] [Abstract] [Full Text] [Related]
3. ER-positive and BRCA2-mutated breast cancer: a literature review.
Li PC; Zhu YF; Cao WM; Li B
Eur J Med Res; 2024 Jan; 29(1):30. PubMed ID: 38184581
[TBL] [Abstract] [Full Text] [Related]
4. Tafazzin mediates tamoxifen resistance by regulating cellular phospholipid composition in ER-positive breast cancer.
Li X; Zhang Y; Zhang T; Zhao L; Lin CG; Hu H; Zheng H
Cancer Gene Ther; 2024 Jan; 31(1):69-81. PubMed ID: 37935981
[TBL] [Abstract] [Full Text] [Related]
5. Towards estimating the carbon footprint of external beam radiotherapy.
Chuter R; Stanford-Edwards C; Cummings J; Taylor C; Lowe G; Holden E; Razak R; Glassborow E; Herbert S; Reggian G; Mee T; Lichter K; Aznar M
Phys Med; 2023 Aug; 112():102652. PubMed ID: 37552912
[TBL] [Abstract] [Full Text] [Related]
6. Lung cancer with breast metastasis: a case report and review of the literature.
Cao X; Chen P; Agyekum EA; Zhang Q; Qian X; Wu T; Chambers KH; Yin L
J Int Med Res; 2023 Jul; 51(7):3000605231188287. PubMed ID: 37523488
[TBL] [Abstract] [Full Text] [Related]
7. Identification, characterization, and prognosis investigation of pivotal genes shared in different stages of breast cancer.
Rommasi F
Sci Rep; 2023 May; 13(1):8447. PubMed ID: 37231064
[TBL] [Abstract] [Full Text] [Related]
8. Nanomedicine in therapeutic warfront against estrogen receptor-positive breast cancer.
Aalhate M; Mahajan S; Singh H; Guru SK; Singh PK
Drug Deliv Transl Res; 2023 Jun; 13(6):1621-1653. PubMed ID: 36795198
[TBL] [Abstract] [Full Text] [Related]
9. MobileNet-SVM: A Lightweight Deep Transfer Learning Model to Diagnose bch Scans for IoMT-Based Imaging Sensors.
Ogundokun RO; Misra S; Akinrotimi AO; Ogul H
Sensors (Basel); 2023 Jan; 23(2):. PubMed ID: 36679455
[TBL] [Abstract] [Full Text] [Related]
10. Hormone receptor binding, selectivity and cytotoxicity of steroid D-homo lactone loaded chitosan nanoparticles for the treatment of breast and prostate cancer cells.
Kuzminac IZ; Ćelić AS; Bekić SS; Kojić V; Savić MP; Ignjatović NL
Colloids Surf B Biointerfaces; 2022 Aug; 216():112597. PubMed ID: 35636320
[TBL] [Abstract] [Full Text] [Related]
11. Nanomedicine-Based Delivery Strategies for breast cancer treatment and Management.
Tagde P; Najda A; Nagpal K; Kulkarni GT; Shah M; Ullah O; Balant S; Rahman MH
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269998
[TBL] [Abstract] [Full Text] [Related]
12. Muscle mass affects paclitaxel systemic exposure and may inform personalized paclitaxel dosing.
Hertz DL; Chen L; Henry NL; Griggs JJ; Hayes DF; Derstine BA; Su GL; Wang SC; Pai MP
Br J Clin Pharmacol; 2022 Jul; 88(7):3222-3229. PubMed ID: 35083783
[TBL] [Abstract] [Full Text] [Related]
13. Pulmonary Tumor Embolism Microangiopathy: A Cause of Respiratory Failure in Advanced Malignancy.
Anwar K; Hanafi M; Mishall B; Bhatt D; Jain R
S D Med; 2021 Oct; 74(10):463-466. PubMed ID: 34995427
[TBL] [Abstract] [Full Text] [Related]
14. Aptamer grafted nanoparticle as targeted therapeutic tool for the treatment of breast cancer.
Sheikh A; Md S; Kesharwani P
Biomed Pharmacother; 2022 Feb; 146():112530. PubMed ID: 34915416
[TBL] [Abstract] [Full Text] [Related]
15. Impact of TAILORx on chemotherapy prescribing and 21-gene recurrence score-guided treatment costs in a population-based cohort of patients with breast cancer.
Tesch ME; Speers C; Diocee RM; Gondara L; Peacock SJ; Nichol A; Lohrisch CA
Cancer; 2022 Feb; 128(4):665-674. PubMed ID: 34855202
[TBL] [Abstract] [Full Text] [Related]
16. Association of ERα-36 expression with the de novo resistance of tamoxifen in ER-positive breast cancer.
Juliansyah A; Rahman S; Indra I; Nelwan B; Prihantono P
Breast Dis; 2021; 40(S1):S123-S127. PubMed ID: 34057127
[TBL] [Abstract] [Full Text] [Related]
17. cancer treatment-Induced Bone Loss (CTIBL): State of the Art and Proper Management in breast cancer Patients on Endocrine Therapy.
Diana A; Carlino F; Giunta EF; Franzese E; Guerrera LP; Di Lauro V; Ciardiello F; Daniele B; Orditura M
Curr Treat Options Oncol; 2021 Apr; 22(5):45. PubMed ID: 33864145
[TBL] [Abstract] [Full Text] [Related]
18. breast metastasis from medullary thyroid carcinoma mimicking ductal carcinoma with neuroendocrine differentiation.
Laforga JB; Dominguez E; Aranda FI
Cancer Rep (Hoboken); 2020 Dec; 3(6):e1292. PubMed ID: 33025739
[TBL] [Abstract] [Full Text] [Related]
19. Randomized Controlled Trial of Trastuzumab With or Without Chemotherapy for HER2-Positive Early breast cancer in Older Patients.
Sawaki M; Taira N; Uemura Y; Saito T; Baba S; Kobayashi K; Kawashima H; Tsuneizumi M; Sagawa N; Bando H; Takahashi M; Yamaguchi M; Takashima T; Nakayama T; Kashiwaba M; Mizuno T; Yamamoto Y; Iwata H; Kawahara T; Ohashi Y; Mukai H;
J Clin Oncol; 2020 Nov; 38(32):3743-3752. PubMed ID: 32936713
[TBL] [Abstract] [Full Text] [Related]
20. breast cancer: are long-term and intermittent endocrine therapies equally effective?
Engel J; Schubert-Fritschle G; Emeny R; Hölzel D
J Cancer Res Clin Oncol; 2020 Aug; 146(8):2041-2049. PubMed ID: 32472445
[TBL] [Abstract] [Full Text] [Related]
[Next]
